Methotrexate: what are the true risks of treatment?

Ann Rheum Dis. 2020 Oct;79(10):1267-1268. doi: 10.1136/annrheumdis-2020-217207. Epub 2020 Jul 1.

Authors

Anja Strangfeld¹, Gerd R Burmester²

Affiliations

¹ Programmbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum Berlin, ein Leibniz Institut, Berlin 10117, Germany [email protected].
² Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany.

PMID: 32611600
DOI: 10.1136/annrheumdis-2020-217207

No abstract available

Keywords: arthritis, rheumatoid; epidemiology; therapeutics.

Publication types

Comment

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Humans
Methotrexate / therapeutic use

Substances

Antirheumatic Agents
Methotrexate